Business Context and Reporting Period
This Form 8-K reports on the 2018 Annual Meeting of Stockholders held by XpresSpa Group, Inc. on September 18, 2018. The filing details the results of shareholder votes on director elections, auditor ratification, and corporate governance proposals. A quorum of 24,540,050 shares (80.51% of outstanding shares) was present.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding corporate governance events and does not contain financial performance data.
Material Changes and Voting Results
The following material actions were approved by shareholders:
- Board Elections: Five nominees (Edward Jankowski, Bruce T. Bernstein, Donald E. Stout, Salvatore Giardina, Richard K. Abbe) were elected or re-elected. Andrew R. Heyer was elected by Preferred Stock holders.
- Auditor Ratification: CohnReznick LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2018.
- Stock Issuance Authorization: Shareholders approved the issuance of common stock underlying convertible notes and warrants issued on May 15, 2018, to comply with Nasdaq Listing Rule 5635(d), even if the issuance exceeds 20% of outstanding stock.
- Reverse Stock Split: An amendment to the Certificate of Incorporation was approved to effect a reverse stock split of common stock at a ratio between 5-for-1 and 25-for-1.
- Executive Compensation: The advisory vote on named executive officer compensation was approved.
- Adjournment: A proposal to adjourn the meeting to solicit additional proxies if necessary was approved.
Voting Discrepancy Note: The Inspector of Election determined that certain in-person votes were invalid due to improper proxy forms. The filing states that even if these votes had been counted against the proposals, all proposals would still have been approved.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, or contingencies beyond the standard corporate governance disclosures. The approval of the reverse stock split and the authorization of significant share issuance for convertible notes indicate ongoing capital structure management.
Investor Verification Checklist
- Verify the implementation timeline and specific ratio of the approved reverse stock split (5-for-1 to 25-for-1).
- Review the terms of the Securities Purchase Agreement dated May 15, 2018, regarding the convertible notes and warrants authorized for issuance.
- Confirm the impact of the "full-ratchet" anti-dilution provisions on existing common shareholders.
- Check subsequent filings for the official effective date of the reverse stock split and the updated share count.